Abstract:Amycolatopsis sp. strain TNS106 harbors a ristomycin-biosynthetic gene cluster (asr) in its genome and produces ristomycin A. Deletion of the sole cluster-situated StrR family regulatory gene, asrR, abolished ristomycin A production and the transcription of the asr genes orf5 to orf39. The ristomycin A fermentation titer in Amycolatopsis sp. strain TNS106 was dramatically improved by overexpression of asrR and a heterologous StrR family regulatory gene, bbr, from the balhimycin-biosynthetic gene cluster (BGC) utilizing strong promoters and multiple gene copies. Ristomycin A production was improved by approximately 60-fold, resulting in a fermentation titer of 4.01 g/liter in flask culture, in one of the engineered strains. Overexpression of AsrR and Bbr upregulated transcription of tested asr biosynthetic genes, indicating that these asr genes were positively regulated by AsrR and Bbr. However, only the promoter region of the asrR operon and the intergenic region upstream of orf12 were bound by AsrR and Bbr in gel retardation assays, suggesting that AsrR and Bbr directly regulated the asrR operon and probably orf12 to orf14 but no other asr biosynthetic genes. Further assays with synthetic short probes showed that AsrR and Bbr specifically bound not only probes containing the canonical inverted repeats but also a probe with only one 7-bp element of the inverted repeats in its native context. AsrR and Bbr have an N-terminal ParB-like domain and a central winged helix-turn-helix DNA-binding domain. Site-directed mutations indicated that the N-terminal ParB-like domain was involved in activation of ristomycin A biosynthesis and did not affect the DNA-binding activity of AsrR and Bbr. IMPORTANCE This study showed that overexpression of either a native StrR family regulator (AsrR) or a heterologous StrR family regulator (Bbr) dramatically improved ristomycin A production by increasing the transcription of biosynthetic genes directly or indirectly. The conserved ParB-like domain of AsrR and Bbr was demonstrated to be involved in the regulation of asr BGC expression. These findings provide new insights into the mechanism of StrR family regulators in the regulation of glycopeptide antibiotic biosynthesis. Furthermore, the regulator overexpression plasmids constructed in this study could serve as valuable tools for strain improvement and genome mining for new glycopeptide antibiotics. In addition, ristomycin A is a type III glycopeptide antibiotic clinically used as a diagnostic reagent due to its side effects. The overproduction strains engineered in this study are ideal materials for industrial production of ristomycin A.

Stability of Plasmid Pa387 Derivatives in Amylcolatopsis Mediterranei Producing Rifamycin

[Characterization of Amycolatopsis Meditteranei U32 Chromosome by Pulse-Field Gel Electrophoresis].

Conjugation of ϕBT1-derived integrative plasmid pDZL802 in Amycolatopsis mediterranei U32.

Analysis of functions in plasmid pHZ1358 influencing its genetic and structural stability in Streptomyces lividans 1326

Amycolatopsis mediterranei : A Sixty-Year Journey from Strain Isolation to Unlocking Its Potential of Rifamycin Analogue Production by Combinatorial Biosynthesis

Characterization of plasmid pXL100 from Amycolatopsis orientalis HCCB10007 and construction of a shuttle vector.

Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699

Global Effect of an RNA Polymerase Β-Subunit Mutation on Gene Expression in the Radiation-Resistant Bacterium Deinococcus Radiodurans

[Study on the Genetic Structure and Transmission Mechanism of a Plasmid-Mediated AmpC Beta-Lactamase].

Efficient Transposition of IS204-derived Plasmids in Streptomyces Coelicolor.

Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B.

[Establishment of Gene Replacement/disruption System Through Homologous Recombination in Amycolatopsis Mediterranei U32].

Complete Genome Sequence of the Rifamycin Sv-Producing Amycolatopsis Mediterranei U32 Revealed Its Genetic Characteristics in Phylogeny and Metabolism

Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes

Identification and Characterization of Glna Promoter and Its Corresponding Trans-Regulatory Protein GlnR in the Rifamycin SV Producing Actinomycete, Amycolatopsis Mediterranei U32.

Genome-based rational engineering of Actinoplanes deccanensis for improving fidaxomicin production and genetic stability

RifZ (AMED_0655) is a Pathway-Specific Regulator for Rifamycin Biosynthesis in Amycolatopsis Mediterranei

Elimination of Indigenous Linear Plasmids in Streptomyces Hygroscopicus Var. Jinggangensis and Streptomyces Sp. FR008 to Increase Validamycin A and Candicidin Productivities.

Plasmid-Stabilizing Strains for Antibiotic-Free Chemical Fermentation

Stability of Integrated Plasmids in the Chromosome of Lactococcus lactis

Improving the Plasmid Stability by a Hok/Sok System for L-Homoserine Production in Escherichia Coli